86940 Federal Register / Vol. 85, No. 251 / Thursday, December 31, 2020 / Notices 

information updates, go to the NACNEP 

website meeting page at https://

www.hrsa.gov/advisory-committees/ 

nursing/meetings.html. 

FOR FURTHER INFORMATION CONTACT: 

Camillus Ezeike, Ph.D., JD, LLM, RN, 

PMP, Designated Federal Official, 

Division of Nursing and Public Health, 

Bureau of Health Workforce, HRSA, 

5600 Fishers Lane, Rockville, 11N–120, 

Maryland 20857; 301–443–2866; or 

BHWNACNEP@hrsa.gov. 

SUPPLEMENTARY INFORMATION: The 

NACNEP provides advice and 

recommendations to the Secretary of 

HHS (Secretary) on policy, program 

development, and other matters of 

significance concerning the activities 

carried out under Title VIII of the Public 

Health Service (PHS) Act, including the 

range of issues relating to the nurse 

workforce, education, and practice 

improvement. NACNEP also prepares 

and submits an annual report to the 

Secretary of HHS and Congress 

describing its activities, including 

NACNEP’s findings and 

recommendations concerning activities 

under Title VIII, as required by the PHS 

Act. Since priorities dictate meeting 

times, be advised that start times, end 

times, and agenda items are subject to 

change. For CY 2021 meetings, agenda 

items may include, but are not limited 

to, a review of federal nursing workforce 

programs, funding for nursing practice 

improvement and nursing education, 

and the response to the COVID–19 

pandemic. Refer to the NACNEP website 

listed above for all current and updated 

information concerning the CY 2021 

NACNEP meetings, including agendas 

and meeting materials that will be 

posted 30 calendar days before the 

meeting. 

Members of the public will have the 

opportunity to provide comments. 

Public participants may submit written 

statements in advance of the scheduled 

meeting(s). Oral comments will be 

honored in the order they are requested 

and may be limited as time allows. 

Requests to submit a written statement 

or make oral comments to the NACNEP 

should be sent to Camillus Ezeike using 

the contact information above at least 5 

business days before the meeting 

date(s). 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Camillus 

Ezeike using the contact information 

listed above at least 10 business days 

before the meeting(s) they wish to 

attend. 

If a meeting is held in-person, it will 

occur in a federal government building 

and attendees must go through a 

security check to enter. Non-U.S. 

Citizen attendees must notify HRSA of 

their planned attendance at an in-person 

meeting at least 20 business days prior 

to the meeting in order to facilitate their 

entry into the building. All attendees are 

required to present government-issued 

identification prior to entry. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2020–28920 Filed 12–30–20; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

RIN 0917–AA19 

Reimbursement Rates for Calendar 

Year 2021 

AGENCY: Indian Health Service (IHS), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: Notice is provided that the 

Director of the Indian Health Service 

has approved the rates for inpatient and 

outpatient medical care provided by IHS 

facilities for Calendar Year 2021. 

SUPPLEMENTARY INFORMATION: The 

Director of the Indian Health Service 

(IHS), under the authority of sections 

321(a) and 322(b) of the Public Health 

Service Act (42 U.S.C. 248 and 249(b)), 

Public Law 83–568 (42 U.S.C. 2001(a)), 

and the Indian Health Care 

Improvement Act (25 U.S.C. 1601 et 

seq.), has approved the following rates 

for inpatient and outpatient medical 

care provided by IHS facilities for 

Calendar Year 2021 for Medicare and 

Medicaid beneficiaries, beneficiaries of 

other federal programs, and for 

recoveries under the Federal Medical 

Care Recovery Act (42 U.S.C. 2651– 

2653). The inpatient rates for Medicare 

Part A are excluded from the table 

below. That is because Medicare 

inpatient payments for IHS hospital 

facilities are made based on the 

prospective payment system, or (when 

IHS facilities are designated as Medicare 

Critical Access Hospitals) on a 

reasonable cost basis. Since the 

inpatient per diem rates set forth below 

do not include all physician services 

and practitioner services, additional 

payment shall be available to the extent 

that those services are provided. 

Inpatient Hospital Per Diem Rate 

(Excludes Physician/Practitioner 

Services) 

Calendar Year 2021 

Lower 48 States $3,631 

Alaska $3,384 

Outpatient Per Visit Rate (Excluding 

Medicare) 

Calendar Year 2021 

Lower 48 States $519 

Alaska $808 

Outpatient Per Visit Rate (Medicare) 

Calendar Year 2021 

Lower 48 States $414 

Alaska $662 

Medicare Part B Inpatient Ancillary Per 

Diem Rate 

Calendar Year 2021 

Lower 48 States $678 

Alaska $1,039 

Outpatient Surgery Rate (Medicare) 

Established Medicare rates for 

freestanding Ambulatory Surgery 

Centers. 

Effective Date for Calendar Year 2021 

Rates 

Consistent with previous annual rate 

revisions, the Calendar Year 2021 rates 

will be effective for services provided 

on/or after January 1, 2021, to the extent 

consistent with payment authorities, 

including the applicable Medicaid State 

plan. 

Michael D. Weahkee, 

Assistant Surgeon General, RADM, U.S. 

Public Health Service, Director, Indian Health 

Service. 

[FR Doc. 2020–28950 Filed 12–30–20; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

General Medical Sciences Council. 

The meeting will be open to the 

public as indicated below, with a short 

public comment period at the end. The 

open session will be videocast and can 

be accessed from the NIH Videocasting 

and Podcasting website (http://

videocast.nih.gov). 

The meeting will be closed to the 

public in accordance with the 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 251 / Thursday, December 31, 2020 / Notices 86941 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

General Medical Sciences Council. 

Date: September 1–2, 2021. 

Open: September 1, 2021, 9:30 a.m. to 

12:00 p.m. 

Agenda: For the discussion of program 

policies and issues; opening remarks; report 

of the Director, NIGMS; and other business 

of the Council. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Virtual Meeting). 

Closed: September 1, 2021, 12:00 p.m. to 

5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Open: September 2, 2021, 9:30 a.m. to 

12:00 p.m. 

Agenda: For the discussion of program 

policies and issues; opening remarks; report 

of the Director, NIGMS; and other business 

of the Council. 

Place: National Institutes of Health, 

Natcher Building, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Closed: September 2, 2021, 12:00 p.m. to 

5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Erica L. Brown, Ph.D., 

Acting Associate Director for Extramural 

Activities, National Institute of General 

Medical Sciences, National Institutes of 

Health, Natcher Building, Room 2AN24F, 

Bethesda, MD 20892, (301) 594–4499, 

erica.brown@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.nigms.nih.gov/About/Council, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives; 93.859, 

Biomedical Research and Research Training, 

National Institutes of Health, HHS) 

Dated: December 23, 2020. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–28902 Filed 12–30–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Cell Biology 

Integrated Review Group; Cellular Signaling 

and Regulatory Systems Study Section. 

Date: January 28–29, 2021. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: David Balasundaram, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5189, 

MSC 7840, Bethesda, MD 20892, (301) 435– 

1022, balasundaramd@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Biobehavioral Medicine and Health 

Outcomes Study Section. 

Date: February 1–2, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Mark Allen Vosvick, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110 

Bethesda, MD 20892 (301) 402–4128, 

mark.vosvick@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 23, 2020. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–28936 Filed 12–30–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; R13 Conference 

Grant Applications. 

Date: February 25, 2021. 

Time: 11:00 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Video 

Meeting). 

Contact Person: Jian Yang, Ph.D., Scientific 

Review Officer, Review Branch, Division of 

Extramural Activities, NIDDK, National 

Institutes of Health, Room 7111, 6707 

Democracy Boulevard, Bethesda, MD 20892– 

5452, (301) 594–7799, yangj@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: December 23, 2020. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–28935 Filed 12–30–20; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES